TARIS Biomedical Garners $18,300,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60f17ac6-da75-4fa5-8ede-d3fe2f982e1c&Preview=1 - Date
4/13/2011 - Company Name
TARIS Biomedical - Mailing Address
99 Hayden Avenue Lexington, MA 02421 - Company Description
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. - Website
http://www.tarisbiomedical.com - Transaction Type
Venture Equity - Transaction Amount
$18,300,000 - Transaction Round
Series B - Proceeds Purposes
This investment will allow us to advance our lead product candidate, Lidocaine Releasing Intravesical System (LiRIS®), into later stage clinical development for the treatment of multiple bladder disorders, and to continue to build the rest of our pipeline of novel therapeutics, leveraging common, minimally invasive urological procedures. The company’s prior bridge financing was also converted into equity in connection with the round. - M&A Terms
- Venture Investor
Third Rock Ventures - Venture Investor
Flagship Ventures - Venture Investor
Flybridge Capital Partners - Venture Investor
Polaris Venture Partners
